<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02889601</url>
  </required_header>
  <id_info>
    <org_study_id>RC12_0463</org_study_id>
    <nct_id>NCT02889601</nct_id>
  </id_info>
  <brief_title>DAPHNE Scale Validation in Frontotemporal Lobar Degeneration</brief_title>
  <acronym>DAPHNE</acronym>
  <official_title>Psycho-behavioral Disorders in Frontotemporal Lobar Degeneration: Validation of a Quantification and Follow-up Scale</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nantes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Psycho-behavioral disorders assessment is crucial for the diagnosis and follow-up of patients
      with frontotemporal degeneration (FTD). DAPHNE scientific staff have therefore developed a
      quantification and follow-up scale specifically dedicated to patients with FTD in current
      clinical practice. This scale is called DAPHNE to Disinhibition, Apathy, Perseveration, Hyper
      orality, Negligence and loss of Empathy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Psycho-behavioral disorders assessment is crucial for the diagnosis and follow-up of patients
      with frontotemporal degeneration (FTD). DAPHNE scientific staff have therefore developed a
      quantification and follow-up scale specifically dedicated to patients with FTD in current
      clinical practice. This scale is called DAPHNE to Disinhibition, Apathy, Perseveration,
      Hyperorality, Negligence and loss of Empathy. This study aims to validate this scale. This
      validation will include methodological steps required to develop a new clinical tool, by
      studying internal consistency, loyalty, and concurrent validity in comparison with validated
      existing tools. Complementarily, sensitivity and specificity will be assessed via a control
      population including patients with Alzheimer's disease, , progressive supranuclear palsy and
      bipolar disorder with cognitive disorders.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 2013</start_date>
  <completion_date type="Actual">December 31, 2015</completion_date>
  <primary_completion_date type="Actual">December 31, 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Internal validation of DAPHNE Score</measure>
    <time_frame>Baseline</time_frame>
    <description>Face validity - Structural validity - Convergent Validity - Known-groups validity - Responses consistency - Reliability</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">89</enrollment>
  <condition>Frontotemporal Lobar Degeneration</condition>
  <arm_group>
    <arm_group_label>Fronto-temporal lobar degeneration</arm_group_label>
    <description>DAPHNE score building and internal validation through Fronto-temporal lobar degeneration patients.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>External validation of DAPHNE score among patients with Alzheimer's disease, progressive supranuclear palsy and bipolar disorder with cognitive disorders.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Psycho-behavioural assessment</intervention_name>
    <description>DAPHNE Scale</description>
    <arm_group_label>Fronto-temporal lobar degeneration</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with Frontotemporal lobar degeneration according Neary (1998) and Raskowsky (2011)
        diagnostic criteria.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Group 1:

          1. Patients with FTD according Neary (1998) and Raskowsky (2011) diagnostic criteria.

          2. Mini-Mental State Examination ≥ 18

          3. Consent

        Group 2 Control:

          1. Patients with Alzheimer's disease (MacKahn, 2011), patients with supranuclear palsy
             (Litvan, 1996) and patients with bipolar disorder with cognitive disorders.

             criteria.

          2. Mini-Mental State Examination ≥ 18

          3. Consent

        Exclusion Criteria:

          -  Minor patient
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Nantes University Hospital</name>
      <address>
        <city>Nantes</city>
        <zip>44000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 24, 2016</study_first_submitted>
  <study_first_submitted_qc>August 30, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 5, 2016</study_first_posted>
  <last_update_submitted>August 16, 2017</last_update_submitted>
  <last_update_submitted_qc>August 16, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Frontotemporal Lobar Degeneration</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

